Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations

por Alexander Höllein, Niroshan Nadarajah, Manja Meggendorfer, Sabine Jeromin, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach
Publicado 2019-02-01

Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 cases.

por Annette Fasan, Tamara Alpermann, Claudia Haferlach, Vera Grossmann, Andreas Roller, Alexander Kohlmann, Christiane Eder, Wolfgang Kern, Torsten Haferlach, Susanne Schnittger
Publicado 2013-01-01

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

por Panagiotis Baliakas, Blanca Espinet, Clemens Mellink, Marie Jarosova, Anastasia Athanasiadou, Paolo Ghia, Arnon P. Kater, David Oscier, Claudia Haferlach, Kostas Stamatopoulos, on behalf of ERIC, the European Research Initiative on CLL
Publicado 2022-04-01

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

por Linus Wahnschaffe, Till Braun, Sanna Timonen, Anil K. Giri, Alexandra Schrader, Prerana Wagle, Henrikki Almusa, Patricia Johansson, Dorine Bellanger, Cristina López, Claudia Haferlach, Marc-Henri Stern, Jan Dürig, Reiner Siebert, Satu Mustjoki, Tero Aittokallio, Marco Herling
Publicado 2019-11-01

The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CT

por Xiang Zhou, Alexander Dierks, Olivia Kertels, Samuel Samnick, Malte Kircher, Andreas K. Buck, Larissa Haertle, Sebastian Knorz, David Böckle, Lukas Scheller, Janin Messerschmidt, Mohammad Barakat, Marietta Truger, Claudia Haferlach, Hermann Einsele, Leo Rasche, K. Martin Kortüm, Constantin Lapa
Publicado 2020-08-01